SUMMARY Coronary arteriography was performed before and after the intracoronary injection of nitroglycerin to determine the presence or absence of spasm in patients within the first 12 hours of acute myocardial infarction. Coronary arterial spasm was demonstrated in six of fifteen (40%) acute myocardial infarctions associated with coronary artery disease. In five of the six instances the interval from the onset of symptoms to arteriography was less than 6 hours. Spasm was superimposed on a high-grade atherosclerotic obstruction and was separated from the catheter tip by a segment of normal vessel in each instance. The coronary artery IN 1973 we demonstrated coronary arterial spasm to be the cause of severe, reversible myocardial ischemia in a patient with Prinzmetal angina.' This has been confirmed repeatedly2-6 and spasm of a normal or atherosclerotic coronary artery is now considered the cause of ischemia in most patients with Prinzmetal angina.7 8 Sewell' and Hellstrom"'"1 discussed the possibility that coronary arterial spasm plays a role in the pathophysiology of acute myocardial infarction (AMI), but spontaneously occurring spasm during AMI has not been proven. Encouraged by our, and others, ability to perform arteriography safely during ischemia in Prinzmetal angina and with the belief that further elucidation of the pathophysiology of AMI will require investigation during the early hours of the process, we performed coronary arteriography (of the artery indicated to be acutely obstructed by the distribution of ST-segment elevation) in 17 patients with AMI to determine if spasm exists.
IN 1973 we demonstrated coronary arterial spasm to be the cause of severe, reversible myocardial ischemia in a patient with Prinzmetal angina.' This has been confirmed repeatedly2-6 and spasm of a normal or atherosclerotic coronary artery is now considered the cause of ischemia in most patients with Prinzmetal angina.7 8 Sewell' and Hellstrom"'"1 discussed the possibility that coronary arterial spasm plays a role in the pathophysiology of acute myocardial infarction (AMI), but spontaneously occurring spasm during AMI has not been proven. Encouraged by our, and others, ability to perform arteriography safely during ischemia in Prinzmetal angina and with the belief that further elucidation of the pathophysiology of AMI will require investigation during the early hours of the process, we performed coronary arteriography (of the artery indicated to be acutely obstructed by the distribution of ST-segment elevation) in 17 patients with AMI to determine if spasm exists.
Methods

Selection of Patients
Patients arriving in the Emergency Department of Denver General Hospital with historical and electrocardiographic evidence of AMI were requested to voluntarily enter the study. A history considered indicative of an AMI consisted of severe, prolonged (greater than 1 hour) ischemic chest pain. Diaphoresis and/or dyspnea were also present. Electrocardiographic changes considered indicative of an AMI consisted of 2 mm or more ST-segment elevation with or without QRS complex changes. Patients were excluded if they 1) were over 70 years of age, 2) had significant left ventricular dysfunction (Killip class III or IV), 3) had frequent PVCs, ventricular tachycardia or transient ventricular fibrillation, 4) had second or third degree block accompanying an acute anterior myocardial infarction, 5) had left or right bundle branch block, 6) had evidence of peripheral vascular disease of the legs, 7) were taking anticoagulants, 8) remained patent (following the initial relief of spasm) in two patients maintained on sublingual nitrates and heparin.
Spasm, superimposed on an atherosclerotic obstruction, may be the primary event or a secondary occurrence in the pathophysiology of acute myocardial infarction. Catecholamines could play an important role in the early pathophysiology of acute myocardial infarction by producing spasm and/or platelet aggregation at the site of an atherosclerotic obstruction. A dynamic interaction between spasm, platelet aggregates and the atherosclerotic plaque may precede coronary thrombosis.
Sometimes family or friends were better able to recall the time of onset of symptoms than the patient. In each instance, the investigators were satisfied, after talking with the patient, family and/or friends, that the time of onset of symptoms could be limited to a 30 minute time periodusually 15 minutes or less. If the time from the onset of symptoms exceeded 12 hours the patient was excluded. Informed consent was always obtained from the patient and frequently from accompanying family.
A total of 106 patients with historical and electrocardiographic evidence of AMI were admitted from October 1974 through March 1976. Fifty-one of these patients were excluded. Of the remaining patients, 25 were not asked to enter the study because the investigators were not contacted within 12 hours from the onset of symptoms, 12 patients refused and 18 patients consented.
Evaluation of Patients
Coronary arteriography was performed by the Judkins technique. In each instance, good quality coronary arteriograms were obtained using 35 mm cine film at 30 frames per second. No premedication with nitroglycerin (NTG) or isosorbide dinitrate was given but some patients had received NTG at home or in the Emergency Room.
In the interest of speed, simplicity and safety arteriography was limited to the coronary artery judged to be acutely occluded, based upon the distribution of STsegment changes on the electrocardiogram (ECG). Left ventricular cineangiography and arteriography of the other coronary artery were not done except in two patients because the initial coronary arteriogram appeared normal.
Two coronary arteriograms in the left anterior oblique (LAO) position were obtained as a baseline. If the artery was totally or subtotally (greater than 90% reduction in diameter) occluded and the ECG showed evidence of an AMI corresponding to the anatomic distribution of the occluded artery, intracoronary NTG was administered. The NTG was injected directly into the coronary artery, as described below, and the arteriogram was repeated 30 seconds and 3 minutes later in the LAO position. Frequently, one arteriogram in the right anterior oblique position was also obtained before and after NTG. In an individual patient, the arteriograms were made with the same CORONARY ARTERIAL SPASM IN AMI/Oliva, Breckinridge quantity of contrast medium and the same force and speed of injection, as judged by the person performing the arteriography. The total amount of contrast medium varied from 22 to 54 cc.
Following completion of the arteriography the patient was transferred to the Coronary Care Unit where he was monitored, observed and treated in the usual fashion.
Preparation of the Nitroglycerin
The NTG was prepared by dissolving a 0.6 mg tablet in 6 cc of sterile normal saline and passing the solution through a Millipore filter. The NTG was injected into the coronary artery within ten minutes of preparation.
Injection of the Nitroglycerin
One hundred micrograms of NTG were injected into an acutely obstructed right coronary artery (RCA) and 300,tg into an acutely obstructed left coronary artery. The NTG was injected rapidly into the RCA in the first case (L.S.). This resulted in some reflux of the drug into the aorta. In all other patients, the NTG was injected slowly over a 30 second period. A small amount of contrast medium was mixed with the NTG and the mixture was administered under fluoroscopy to insure that it was being injected into the coronary artery and that reflux was not occurring.
Recognition of Spasm
Spasm was recognized by the demonstration of 1) an initial total occlusion of a coronary artery and subsequent patency following NTG administration, allowing antegrade filling of the distal vessel, or 2) an initial subtotal occlusion of a coronary artery with slow, incomplete distal filling and subsequent fast, complete distal filling after NTG administration. The coronary arteriograms were independently reviewed by two cardiologists ( Coronary arteriography and left ventricular cine angiography were performed at a later date in six patients. Spasm was sought by the repeat injection of intracoronary NTG into a completely occluded artery.
Results
Clinical Characteristics
Seventeen patients with an AMI were studied within 121/2 hours from the onset of symptoms of infarction (table 1) . One patient (J.B.) had two infarctions 12 days apart. Coronary arteriograms were obtained on both occasions and therefore he is included twice in table 1. The study group is comprised of 13 men and four women whose ages ranged from 36 to 68 with an average age of 52 years. One patient had a prior myocardial infarction and three patients had light calcification of a coronary artery under fluoroscopy.
Since one patient had two separate infarctions, the results consider 18 infarctions in 17 patients.
Activity of Patient at Onset of Symptoms
The activity of the patient at the onset of symptoms of AMI is recorded in table 1. Five patients were resting in bed or asleep, nine patients were sitting or driving a car, two patients were engaged in moderate activity (walking and laying tile) and two were engaged in heavy physical activity (shoveling snow and lifting 40 lb. boxes).
Time Interval from Onset of Symptoms to Arteriography
The time from onset of symptoms to arteriography ranged from 2 to 121/2 hours. This time interval was less than 6 hours in 13 patients and between 6 and 121/2 hours in five patients.
Drugs Prior to Arteriography
Six patients received sublingual NTG at home or in the Emergency Room prior to arteriography. Other cardiac Only one patient died (V.S.). Death occurred from progressive left ventricular dysfunction 2 weeks after the AMI. The RCA was totally occluded and the inferior wall showed an old infarction. The proximal LAD was severely narrowed by the atherosclerotic process and a recent thrombus was present at that site. The arteriogram had shown complete occlusion of the proximal LAD unresponsive to NTG 8 hours and 5 minutes after the onset of symptoms of AMI.
Discussion
The purpose of this investigation was to determine whether or not coronary arterial spasm exists in clinical acute myocardial infarction. The technique of coronary arteriography before and after the administration of intracoronary NTG was used to establish the presence or absence of spasm. Two technical considerations merit mention before discussing the results of this study. The first is that spasm could have been induced by the arteriography catheter. Spasm of the right coronary artery, usually near the tip of the catheter, is a well recognized but infrequent occurrence. 3 15 There are several reasons to believe that the spasm observed in this study was natural rather than induced. 1) Spasm consistently occurred at the site of an atherosclerotic obstruction and was separated from the catheter tip by several centimeters.
2) The occurrence of spasm in four of six patients with right coronary arterial occlusions is much higher than the incidence observed during routine arteriography.* 3) Repeat arteriography five to 12 days later in three of the six patients who had spasm during the acute study demonstrated no spasm. Although there is no way to prove beyond a doubt that the spasm was not induced, these points speak strongly for its natural occurrence. If the spasm were induced then it must be concluded that the coronary arteries have an exceptional propensity to develop spasm during arteriography in patients with AMI.
The second technical consideration pertains to the injection of intracoronary NTG in patients with LAD or circumflex occlusions. In these patients it is possible that following injection of NTG into the left main coronary artery the drug preferentially flowed into the nonoccluded, lower resistance vessels arising proximal to the occlusion. The frequently observed delayed clearance of contrast medium from the segment of vessel between the acute occlusion and the first proximal branch suggests a higher resistance to flow in that segment. The fact that contrast medium reached the site of occlusion does not imply that NTG also did because the volume, speed and force of injection of contrast medium exceeded that of NTG. For The pathophysiology of AMI is uncertain. Differences of opinion exist concerning the relationship of coronary thrombosis to AMI.i7 Spain,", i9 Baroldi,20 Roberts,2' Ehrlich,22 Branwood2 and Erhardt24 have expressed the opinion that coronary thrombosis may be the consequence rather than the cause of AMI. The various observations leading to this belief include: 1) the low incidence of coronary arterial thrombi in patients dying suddenly from ischemic heart dis-CORONARY ARTERIAL SPASM IN AMI/Oliva, Breckinridge ease; 2) the increased frequency of thrombi as the time interval from the onset of symptoms of AMI to death increases; 3) the frequent disparity between the histologic age of an occlusive thrombus and the age of its related infarct; 4) the higher incidence of thrombi in patients dying from severe left ventricular dysfunction following an AMI; and 5) the incorporation in thrombi of radioactive fibrinogen injected after the onset of symptoms of AMI.
Coronary arterial spasm provides a reasonable explanation for the concept that thrombosis follows infarction. Spasm may initiate AMI. It is possible that spasm superimposed on a subtotal atherosclerotic obstruction produces complete occlusion with subsequent infarction and thrombosis. This hypothesis is not proved by this investigation, but it deserves further consideration. It is equally possible that spasm is merely secondary to one or more stimuli: an intimal hemorrhage irritating the adjacent muscular media, local hyperkalemia, vasoactive substances released from platelet aggregates or increased catecholamines acting on a-adrenergic receptors.
An interaction between platelet aggregates and spasm is especially interesting. Platelet aggregates are present in the epicardial and intramyocardial arteries of patients with coronary artery disease who die suddenly. 25 26 Platelet aggregates also form at or just distal to a site of experimental coronary arterial constriction. 27 The release from platelet aggregates of vasoactive substances such as serotonin, prostaglandin G2, and the newly discovered compound, thromboxane A2,28 may produce spasm. Thus, platelet aggregation may lead to spasm and the constriction may promote further platelet aggregation. Catecholamines can cause both platelet aggregation and coronary arterial constriction.29' 30 A transient sympathetic discharge -perhaps related to cigarette smoking,3' the rapid eye movement (REM) phase of sleep,32 or other stimuli -could produce spasm with consequent disruption of the plaque surface and platelet aggregation; alternatively, platelet aggregation could occur initially with spasm resulting from released vasoconstrictor substances.
Some pathologists have questioned the ability of a sclerotic coronary artery to constrict.33 Others have found an increased amount of muscle in the media of atherosclerotic coronary arteries and arterioles, except those that are severely diseased and calcified.34' This increase of muscle in the media provides an anatomic basis for the possibility that spasm superimposed on an atherosclerotic obstruction can produce coronary occlusion.
None of the patients in this series had extensive coronary arterial calcification under fluoroscopy and all were under the age of 70 (mean age 52 years). Younger patients without severely sclerotic coronary arteries may develop spasm while older patients or those with severely sclerotic, calcified vessels may be unable to develop spasm. The pathophysiology of AMI may be variable and depend, at least in part, upon anatomical and functional characteristics of the coronary arteries.
Clinical Implications
The relief of coronary arterial spasm and restoration of some blood flow to ischemic myocardium is a form of limited myocardial reperfusion. Many studies have been conducted on the effect of complete reperfusion of ischemic myocardium36 -4 with variable effects on infarct size, contractility and histology being observed. The effect of complete reperfusion is related to the time interval between onset of ischemia and reperfusion and the duration of reperfusion.
Only a few studies have been conducted on the effect of small increments of oxygen tension on ischemic myocardium -a situation which may be analogous to the limited reperfusion of ischemic myocardium following the relief of spasm. Mueller et al. 46 and Maroko et al. 47 have demonstrated that small increments in oxygen tension can improve the contractility of ischemic myocardium and reduce infarct size, respectively. In the current clinical study one patient exhibited a reduction in ST-segment elevation and a change in rhythm from complete heart block with a junctional pacemaker to sinus tachycardia concomitant with restoration of blood flow to the inferior wall and A-V node. However, the other five patients displayed no evidence of reduced ischemia. Although no immediate beneficial effects were noted after relief of spasm in these patients, it is recognized that improvement after reperfusion occurs over a period of days to weeks. 44 45 Benefits may be observed beyond the immediate period of study reported here.
NTG rather than contrast medium probably relieved the spasm since at least two arteriograms always preceded NTG administration and no effect was noted from the contrast alone. Improved distal flow ( fig. IB and C) could be due to either relief of distal spasm or reduced myocardial edema secondary to the hyperosmolarity of the contrast medium.48
Further investigation will be necessary to determine if patency of the coronary artery can be pharmacologically maintained and, if so, whether such patency and the restoration of some blood flow is beneficial. Preliminary observations on two patients in this study with spasm who received frequent sublingual isosorbide dinitrate following the initial relief of spasm and were subsequently shown to have a patent coronary artery, suggest that prolonged relief of spasm may be feasible.
Conclusion
Coronary arterial spasm has been shown to exist within 10½12 hours from the onset of symptoms in six of 15 patients with AMI. Such a small series does not allow prediction of how many patients with AMI will have spasm, but the incidence may be higher than the 40% found here because the intracoronary injection of NTG may have prevented detection of spasm in patients with LAD 
